Quantitative analysis of cytomegalovirus viremia in lung transplant recipients

Thomas C. Bailey, Richard S. Buller, Neil A. Ettinger, Elbert P. Trulock, Monique Gaudreault-Keener, Teri M. Langlois, Jane E. Rossiter Fornoff, Joel D. Cooper, Gregory A. Storch

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


A quantitative culture method was used to test serial blood specimens from 28 lung transplant recipients at risk of cytomegalovirus (CMV) infection (donor [D] or recipient [R] seropositive for CMV). Viremia occurred in 26 (93%) of 28 patients. Highest levels were seen when the donor was seropositive. The median of individual maximum levels was 2.13 infectious centers (ICs)/10s leukocytes for D+/R· patients (interquartile range [iqr], 0.12-21.77), 1.01 for D+/R+ (iqr, 0.32.32), and 0.10 for D·/R+ [iqr, 0.07-0.36; P =.030, Kruskal-Wallis test). Higher levels were seen in patients with biopsy-proven CMV pneumonitis compared with those with negative biopsies (mean, 0.24 [SD 0.51] ICs/105 leukocytes vs. 0.01 [SD 0.03]; P =.039, Wilcoxon test) and with symptomatic CMV episodes compared with asymptomatic episodes (median, 0.34 ICs/I0s [iqr, 0.11-0.61] vs. 0.08 ICs/105 [iqr, 0.03-0.13]; P =.045, Wilcoxon test). Further studies are required to determine whether quantification of CMV viremia by this method will be of practical value in the recognition of significant CMV infection in lung transplant recipients.

Original languageEnglish
Pages (from-to)1006-1010
Number of pages5
JournalJournal of Infectious Diseases
Issue number4
StatePublished - Apr 1995


Dive into the research topics of 'Quantitative analysis of cytomegalovirus viremia in lung transplant recipients'. Together they form a unique fingerprint.

Cite this